MTOR and hepatocellular carcinoma: In addition, the combination of SNORA23 and rapamycin blocked two main cascades of PI3K/AKT/mTOR signaling, RPS6 and 4EBP1, resulting in decreased AKT levels and tumorigenesis in an HCC mouse model.